Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN109912624A reveals a streamlined synthetic route for Baloxavir marboxil intermediates, offering significant supply chain reliability and cost advantages for pharmaceutical manufacturers.
Novel rhodium-catalyzed method offers high purity carbazole intermediates with scalable supply chain advantages for global pharmaceutical and electronic chemical manufacturing.
Patent CN115745823A details a novel asymmetric synthesis for high-purity chloramphenicol intermediates, offering cost reduction and scalable manufacturing solutions.
Patent CN115947759A reveals a one-pot Remdesivir synthesis reducing steps and cost. Discover supply chain advantages and high-purity manufacturing insights.
Novel route for Iopamidol production via acylated intermediate. High purity, reduced impurities, and cost-effective manufacturing for global supply chains.
Advanced synthesis of 2-(3,3,3-trifluoropropylthio)adenosine via patent CN108033983B. Offers high yield, safety, and cost reduction in API manufacturing.
Patent CN104910090B details a copper-promoted synthesis for dihydroisoxazoles. This method offers mild conditions and supply chain advantages for pharmaceutical manufacturing.
Patent CN111808106A discloses a novel acid-catalyzed route for pyrrolo[1,2-a]indoles. This method offers high yields, mild conditions, and significant cost reduction potential for supply chains.
Novel Suzuki coupling route for Vimseltinib ensures high purity and scalable production for global pharmaceutical supply chains seeking cost-effective intermediates.
Patent CN108239019A enables enzymatic synthesis of chiral piperidine esters. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN110092735B reveals a high-yield Negishi coupling route for Eluxadoline intermediates, offering significant cost reduction and scalable manufacturing for pharmaceutical clients.
Patent CN115260122B reveals oxidant-mediated cyclization for high-purity naphthothiazole derivatives ensuring cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN114478708B reveals an 8+2 solid-phase method for high-purity ganirelix, offering significant cost reduction and scalable manufacturing for global supply chains.
Patent CN108752379A reveals copper-catalyzed route reducing costs and enhancing supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Patent CN106946887A details catalyst optimization for Dipyridamole. Enhances yield and safety while reducing environmental impact for reliable supply chains.
Patent CN112442060B enables mild copper catalysis for gamma-aminoboronic acid esters. Achieve high purity pharmaceutical intermediates with reduced operational complexity and enhanced supply reliability.
Patent CN114349704A reveals a novel one-pot synthesis for trifluoromethyl-conjugated pyrazole spirocyclopropanes, offering cost-effective routes for pharmaceutical intermediates.
Novel patent CN119528902A offers high-yield KRAS G12D intermediate synthesis. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing partners globally.
Patent CN104710368B reveals high-yield Pd-catalyzed route for quinazolinone intermediates. Delivers supply chain stability and cost efficiency for pharmaceutical manufacturing.
Novel patent CN120118017A details blue LED catalysis for 3-selenocyanoindoles. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.